Presentation is loading. Please wait.

Presentation is loading. Please wait.

What guides your general approach to small lung nodules? A.Institutional guidelines B.National / Society guidelines C.Individualized approach D.Some combination.

Published bySarah Douglas Modified over 9 years ago

Similar presentations

Presentation on theme: "What guides your general approach to small lung nodules? A.Institutional guidelines B.National / Society guidelines C.Individualized approach D.Some combination."— Presentation transcript:

1 What guides your general approach to small lung nodules? A.Institutional guidelines B.National / Society guidelines C.Individualized approach D.Some combination of above A.Institutional guidelines B.National / Society guidelines C.Individualized approach D.Some combination of above Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

2 What are acceptable approaches to small lung nodules for your patients? A.Surgery only B.Surgery, SBRT C.Surgery, SBRT, RFA D.Surgery, SBRT, RFA, and/or cryoablation A.Surgery only B.Surgery, SBRT C.Surgery, SBRT, RFA D.Surgery, SBRT, RFA, and/or cryoablation Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

3 Small lung nodule case#1 79 yoF, former smoker 1.9cm subsolid RUL nodule; no PET nodule enlarging x 9 months Open to clinical trial enrollment FEV1 1.8L, DLCO 72% predicted 79 yoF, former smoker 1.9cm subsolid RUL nodule; no PET nodule enlarging x 9 months Open to clinical trial enrollment FEV1 1.8L, DLCO 72% predicted Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

4

5 Small lung nodule case#1 A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) E.Clinical trial enrollment (eg. CALGB 140503, others) A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) E.Clinical trial enrollment (eg. CALGB 140503, others) Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

6 Small lung nodule case#2 46 yoM, healthy, prior smoker Nodule found ~1 year ago on coronary screening CT scan ~5mm then, now 9mm No uptake on PET FEV1 3.5L 46 yoM, healthy, prior smoker Nodule found ~1 year ago on coronary screening CT scan ~5mm then, now 9mm No uptake on PET FEV1 3.5L Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

7

8 Small lung nodule case#2 A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

9 Small lung nodule case#3 55 yoM, long time smoker, now quit Bad emphysema FEV1 1.1L, DLCO 42% predicted RUL nodule 1.1 cm enlarging x 6 months SUVmax 3.4 55 yoM, long time smoker, now quit Bad emphysema FEV1 1.1L, DLCO 42% predicted RUL nodule 1.1 cm enlarging x 6 months SUVmax 3.4 Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

10

11 Small lung nodule case#3 A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

12 Small lung nodule case#4 Healthy 64 yoM, long time smoker, now quit 1.4cm RUL nodule; SUVmax 4.6 nodule enlarging x 6 months Says no to clinical trial FEV1 2.4L, DLCO 59% predicted Healthy 64 yoM, long time smoker, now quit 1.4cm RUL nodule; SUVmax 4.6 nodule enlarging x 6 months Says no to clinical trial FEV1 2.4L, DLCO 59% predicted Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

13

14 Small lung nodule case#4 A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) A.Observe, F/U CT scan B.Image guided biopsy C.Sublobar resection D.Completion lobectomy (if Cancer) Small Lung Nodules: What do They Really Do? AATS 2015, Seattle WA

Download ppt "What guides your general approach to small lung nodules? A.Institutional guidelines B.National / Society guidelines C.Individualized approach D.Some combination."

Similar presentations

Joseph J. Muscato, MD, FACP Medical Director Stewart Cancer Center, Boone Hospital.

Joseph J. Muscato, MD, FACP Medical Director Stewart Cancer Center, Boone Hospital.
Pulmonary Stereotactic Ablative Radiotherapy:

Pulmonary Stereotactic Ablative Radiotherapy:
J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.

J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.

Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
The Downside of a Cancer Study Extolling CT Scans Tara Parker-Pope NYT – November 15, 2010

The Downside of a Cancer Study Extolling CT Scans Tara Parker-Pope NYT – November 15, 2010
Update in the Management of Thyroid Neoplasms University of Washington

Update in the Management of Thyroid Neoplasms University of Washington
Liver Cancer ACC RNSG 1247. Risk factors 4 th most common cancer in the world Most common primary liver cancer is hepatocellular carcinoma Cirrhosis –

Liver Cancer ACC RNSG Risk factors 4 th most common cancer in the world Most common primary liver cancer is hepatocellular carcinoma Cirrhosis –
Screen discovered nodules: What next? Anil Vachani, MD, MS Assistant Professor of Medicine Director, Lung Nodule Program University of Pennsylvania Medical.

Screen discovered nodules: What next? Anil Vachani, MD, MS Assistant Professor of Medicine Director, Lung Nodule Program University of Pennsylvania Medical.
Radiofrequency ablation of lung tumours Michelle Muller Consultant Radiologist Freeman Hospital.

Radiofrequency ablation of lung tumours Michelle Muller Consultant Radiologist Freeman Hospital.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.

SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.
Sublobar Resection and Intraoperative Brachytherapy for Lung Cancer: ACOSOG Update Rodney J. Landreneau, MD Professor of Surgery The Heart Lung and Esophageal.

Sublobar Resection and Intraoperative Brachytherapy for Lung Cancer: ACOSOG Update Rodney J. Landreneau, MD Professor of Surgery The Heart Lung and Esophageal.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
May 28 – 30, 2015, Montréal, Québec A Canadian Approach to Lung Cancer Screening: What every radiologist should know.

May 28 – 30, 2015, Montréal, Québec A Canadian Approach to Lung Cancer Screening: What every radiologist should know.
Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.

Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.
Pulmonary Physiologic Assessment of Operative Risk.

Pulmonary Physiologic Assessment of Operative Risk.
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.

Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
on behalf of the ACOSOG Z4032 Investigators

on behalf of the ACOSOG Z4032 Investigators
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.

Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
1 CASE #2 Sam Shahpar, MD Instructor, Feinberg School of Medicine at Northwestern University Attending Physician, Cancer Rehabilitation Program at RIC.

1 CASE #2 Sam Shahpar, MD Instructor, Feinberg School of Medicine at Northwestern University Attending Physician, Cancer Rehabilitation Program at RIC.

Similar presentations

Ads by Google